These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23772504)

  • 41. [The metabolic syndrome. Part II: its mechanisms of development and its complications].
    Pacholczyk M; Ferenc T; Kowalski J
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():543-58. PubMed ID: 18936730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes and hypertension: the scope of the problem.
    Galvan AQ; Haffner SM; Ferrannini E
    Blood Press Suppl; 1996; 1():7-9. PubMed ID: 9162443
    [No Abstract]   [Full Text] [Related]  

  • 44. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs.
    German AJ; Hervera M; Hunter L; Holden SL; Morris PJ; Biourge V; Trayhurn P
    Domest Anim Endocrinol; 2009 Nov; 37(4):214-26. PubMed ID: 19674864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications.
    Franco LP; Morais CC; Cominetti C
    Nutr Rev; 2016 Sep; 74(9):558-70. PubMed ID: 27473199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocannabinoid system and cardiometabolic risk.
    Saavedra LE
    Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; Leroith D; Karnieli E
    Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hormones of adipose tissue in diabetes mellitus and its complications (review of literature and the authors'own data)].
    Zak KP; Kondratskaia IN; Popova VV
    Lik Sprava; 2010; (5-6):39-55. PubMed ID: 21488367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The road from obesity to type 2 diabetes.
    Ioannidis I
    Angiology; 2008; 59(2 Suppl):39S-43S. PubMed ID: 18505743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarkers in the field of obesity and its related comorbidities.
    Katsareli EA; Dedoussis GV
    Expert Opin Ther Targets; 2014 Apr; 18(4):385-401. PubMed ID: 24479492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.
    Wilkin TJ
    Int J Obes (Lond); 2009 Jul; 33(7):716-26. PubMed ID: 19506563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms.
    Corbin KD; Driscoll KA; Pratley RE; Smith SR; Maahs DM; Mayer-Davis EJ;
    Endocr Rev; 2018 Oct; 39(5):629-663. PubMed ID: 30060120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
    Tataranni PA
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):27-32. PubMed ID: 12708607
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.
    Koren D; Taveras EM
    Metabolism; 2018 Jul; 84():67-75. PubMed ID: 29630921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults.
    Carvalho LP; Basso-Vanelli RP; Di Thommazo-Luporini L; Mendes RG; Oliveira-Junior MC; Vieira RP; Bonjorno-Junior JC; Oliveira CR; Luporini R; Borghi-Silva A
    Cytokine; 2018 Jul; 107():118-124. PubMed ID: 29246653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Early insulin administration in obese patients with type 2 diabetes makes sense--contra].
    Schusdziarra V
    Dtsch Med Wochenschr; 2008 Apr; 133(17):920. PubMed ID: 18415918
    [No Abstract]   [Full Text] [Related]  

  • 57. [Early insulin administration in obese patients with type 2 diabetes makes sense--pro].
    Dreyer M
    Dtsch Med Wochenschr; 2008 Apr; 133(17):919. PubMed ID: 18415917
    [No Abstract]   [Full Text] [Related]  

  • 58. [Adipokines and the metabolism of key nutrients in patients with obesity].
    Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
    Ter Arkh; 2014; 86(1):45-8. PubMed ID: 24754068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction between adipokines, diet and exercise on muscle insulin sensitivity.
    Stefanyk LE; Dyck DJ
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):255-9. PubMed ID: 20216410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
    Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
    PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.